Does human rotavirus vaccine reduce the incidence of severe rotavirus gastroenteritis in African infants?
Human rotavirus vaccine is effective in reducing severe rotavirus gastroenteritis in African infants during their first year of life.
Human rotavirus vaccine significantly reduced the incidence of severe rotavirus gastroenteritis among African infants during the first year of life. (ClinicalTrials.gov number, NCT00241644.)
Madhi et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: